Skip to main content

Advertisement

Log in

ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2− Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385–93.

    Article  Google Scholar 

  2. Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25(24):3670–9.

    Article  Google Scholar 

  3. Nakauchi C, Naoi Y, Shimazu K, et al. Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsy. Cancer Lett. 2014;353(1):52–8.

    Article  CAS  Google Scholar 

  4. Okuno J, Miyake T, Sota Y, et al. Development of prediction model including microRNA expression for sentinel lymph node metastasis in ER-positive and HER2-negative breast cancer. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08735-9.

    Article  PubMed  Google Scholar 

Download references

Funding

Funding was provided by Japan Society for the Promotion of Science (Grant No. JP18K08569).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomohiro Miyake MD.

Ethics declarations

Disclosure

Shinzaburo Noguchi is an advisory for and has received honoraria and research funding not related to this study from Sysmex and holds joint patents not related to this study with Sysmex. No other authors have declared any conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okuno, J., Miyake, T., Shimazu, K. et al. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2− Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy. Ann Surg Oncol 27 (Suppl 3), 810–811 (2020). https://doi.org/10.1245/s10434-020-08797-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08797-9

Navigation